Efficacy of the Combination of Pinaverium Bromide 100 mg Plus Simethicone 300 mg in Abdominal Pain and Bloating in Irritable Bowel Syndrome: A Randomized, Placebo-controlled Trial.

Journal Information

Full Title: J Clin Gastroenterol

Abbreviation: J Clin Gastroenterol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"M.J.S. has received grant supports from Alfa Wasserman. During the last year, he served as a consultant for Commonwealth Diagnostics International Inc. and has been a speaker for Takeda Mexico. J.C.L.-A. was a Takeda Mexico employee at the time of the trial and J.C.-U. and A.S.-R. are current employees of Takeda Mexico. A.L.-C. has been a speaker for Takeda Mexico and Alfa Wasserman. G.J.M.-P. has been a speaker for Takeda Mexico and Cook Medical. J.M.R.-T. has served on the Advisory Board of Allergan, Carnot, and Sanfer. He has been a consultant for Alfa Wasserman, Almirall, Commonwealth Laboratories Inc., Takeda Mexico, Asofarma Mexico, and Sanfer. He has also been a speaker for Alfa Wasserman, Takeda Mexico, Carnot, Sanfer, and Almirall. He has received grant supports from Alfa Wasserman and Sanfer. S.S.-C. has been a speaker for Takeda Mexico and Cook Medical and has served as a Consultant for Cook Medical. J.C.S.-P. has been a speaker for Takeda Mexico. J.L.T.d.l.C. has been a speaker for Takeda Mexico. O.T.T.-M. has been a speaker for Takeda, Asofarma, and Sanfer and has served as a consultant for Takeda and Menarini."

Evidence found in paper:

"Supported by Takeda Mexico SA de CV (formerly Nycomed). M.J.S. has received grant supports from Alfa Wasserman. During the last year, he served as a consultant for Commonwealth Diagnostics International Inc. and has been a speaker for Takeda Mexico. J.C.L.-A. was a Takeda Mexico employee at the time of the trial and J.C.-U. and A.S.-R. are current employees of Takeda Mexico. A.L.-C. has been a speaker for Takeda Mexico and Alfa Wasserman. G.J.M.-P. has been a speaker for Takeda Mexico and Cook Medical. J.M.R.-T. has served on the Advisory Board of Allergan, Carnot, and Sanfer. He has been a consultant for Alfa Wasserman, Almirall, Commonwealth Laboratories Inc., Takeda Mexico, Asofarma Mexico, and Sanfer. He has also been a speaker for Alfa Wasserman, Takeda Mexico, Carnot, Sanfer, and Almirall. He has received grant supports from Alfa Wasserman and Sanfer. S.S.-C. has been a speaker for Takeda Mexico and Cook Medical and has served as a Consultant for Cook Medical. J.C.S.-P. has been a speaker for Takeda Mexico. J.L.T.d.l.C. has been a speaker for Takeda Mexico. O.T.T.-M. has been a speaker for Takeda, Asofarma, and Sanfer and has served as a consultant for Takeda and Menarini."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025